The Efficacy and Safety of SGLT2 Inhibitor in Diabetic Kidney Transplant Recipients
Jeong‐Hoon Lim(Kyungpook National University Hospital), Jang‐Hee Cho(Kyungpook National University Hospital), Hyung Eun Son(Seoul National University Bundang Hospital), Chan‐Duck Kim(Kyungpook National University Hospital), Jong Cheol Jeong(Seoul National University Bundang Hospital), Jung Pyo Lee(Seoul National University), Yena Jeon(Kyungpook National University), Kyung Don Yoo(Ulsan College), Hajeong Lee(Seoul National University), Yong-Lim Kim(Kyungpook National University Hospital), Young‐Hoon Kim(Kookmin University), Yon Su Kim(Seoul National University), Hyunwook Kwon(Ulsan College), Jeonghwan Lee(FIND), Jong Soo Lee(Ulsan College), Soie Kwon(Seoul National University)
Cited by 114
Related Papers
Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
|Kidney International|2019|425
A Machine Learning Approach Using Survival Statistics to Predict Graft Survival in Kidney Transplant Recipients: A Multicenter Cohort Study
|Scientific Reports|2017|125
High-Dose Versus Conventional-Dose Continuous Venovenous Hemodiafiltration and Patient and Kidney Survival and Cytokine Removal in Sepsis-Associated Acute Kidney Injury: A Randomized Controlled Trial
|American Journal of Kidney Diseases|2016|109
Interdialytic Weight Gain and Cardiovascular Outcome in Incident Hemodialysis Patients
|American Journal of Nephrology|2014|73
Superior outcomes of kidney transplantation compared with dialysis
|Medicine|2016|65